Showing results (141-150 of 251) with videos related to
Sort By:
Pageof 26
Radiology and Oncology|February 3, 2016
Clinical impact of post-progression survival on overall survival in patients with limited-stage disease small cell lung cancer after first-line chemoradiotherapyNorimitsu Kasahara, Hisao Imai, Kyoichi Kaira, et al.Clinical Lung Cancer|September 4, 2017
Clinical Factors Predicting Detection of T790M Mutation in Rebiopsy for EGFR-Mutant Non-small-cell Lung CancerTakahisa Kawamura, Hirotsugu Kenmotsu, Shota Omori, et al.Molecular and Clinical Oncology|May 23, 2017
Amrubicin monotherapy may be an effective second-line treatment for patients with large-cell neuroendocrine carcinoma or high-grade non-small-cell neuroendocrine carcinomaNorimitsu Kasahara, Kazushige Wakuda, Shota Omori, et al.Lung Cancer (Amsterdam, Netherlands)|April 16, 2024
Long-term follow-up and exploratory analysis of lenvatinib in patients with metastatic or recurrent thymic carcinoma: Results from the multicenter, phase 2 REMORA trialSeiji Niho, Jun Sato, Miyako Satouchi, et al.BMC Cancer|December 23, 2015
Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancerHisao Imai, Kyoichi Kaira, Keita Mori, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 20, 2012
Prognostic impact of circulating tumor cells in patients with small cell lung cancerTateaki Naito, Fumihiro Tanaka, Akira Ono, et al.Thoracic Cancer|May 21, 2025
Desensitizing Effect of Intra-Tumoral GDF-15 on Immunotherapy in Patients With Advanced Non-Small Cell Lung CancerNaoya Nishioka, Tateaki Naito, Takashi Sugino, et al.Investigational New Drugs|May 28, 2021
Comparison of clinical features between immune-related sclerosing cholangitis and hepatitisMasaki Takinami, Akira Ono, Takanori Kawabata, et al.Lung Cancer (Amsterdam, Netherlands)|July 22, 2010
Biologic correlates of ¹⁸F-FDG uptake on PET in pulmonary pleomorphic carcinomaKyoichi Kaira, Masahiro Endo, Masato Abe, et al.Oncology Reports|September 3, 2010
CD98 expression is associated with the grade of malignancy in thymic epithelial tumorsKyoichi Kaira, Toshiaki Takahashi, Masato Abe, et al.Pageof 26